Russell Investments Group
DNTH icon

Russell Investments Group’s Dianthus Therapeutics DNTH Stock Holding History

Russell Investments Group’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14M Buy
143,431
+14,366
+11% +$1.25M 0.01% 897
2026
Q1 		$10.8M Buy
129,065
+40,776
+46% +$2.36M 0.01% 893
2025
Q4 		$3.64M Buy
88,289
+86,671
+5,357% +$3.36M ﹤0.01% 1522
2025
Q3 		$63.7K Buy
+1,618
New +$41.4K ﹤0.01% 3182
2022
Q1 		– Sell
-134
Closed -$9K – 2790
2021
Q4 		$9K Hold
134
– – ﹤0.01% 2978
2021
Q3 		$15K Sell
134
-259
-66% -$30.2K ﹤0.01% 3005
2021
Q2 		$60K Sell
393
-1,797
-82% -$330K ﹤0.01% 3114
2021
Q1 		$414K Sell
2,190
-2,720
-55% -$458K ﹤0.01% 2599
2020
Q4 		$614K Sell
4,910
-700
-12% -$79.4K ﹤0.01% 2341
2020
Q3 		$608K Buy
5,610
+2,852
+103% +$338K ﹤0.01% 2306
2020
Q2 		$330K Buy
2,758
+85
+3% +$12K ﹤0.01% 2544
2020
Q1 		$270K Buy
2,673
+1,506
+129% +$279K ﹤0.01% 2442
2019
Q4 		$282K Sell
1,167
-2,686
-70% -$502K ﹤0.01% 2601
2019
Q3 		$631K Buy
+3,853
New +$732K ﹤0.01% 2212

Other funds holding DNTH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $603M AUM 111.06% 1-Year Est. Return

Russell Investments Group's DNTH Position: Q2 2026 in Review

Russell Investments Group increased its Dianthus Therapeutics (DNTH) stake by 11% in Q2 2026, buying an estimated $1.25M and bringing the position to 143,431 shares worth $14M. The position accounts for 0.01% of the portfolio, ranked #897.

Russell Investments Group first reported a position in DNTH in Q3 2019 and has held it in 14 quarters since. 84 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

  • Russell Investments Group held 143,431 shares of Dianthus Therapeutics worth $14M as of Q2 2026.
  • Russell Investments Group bought 14,366 Dianthus Therapeutics shares in Q2 2026, an estimated $1.25M.
  • Dianthus Therapeutics made up 0.01% of Russell Investments Group's portfolio in Q2 2026, its #897 holding.
  • Russell Investments Group first reported a position in Dianthus Therapeutics in Q3 2019 and has held it in 14 quarters since.
  • 84 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.